Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Global Strategic Communications:
David Verga

Email: media@path.org

Recent Press Coverage

  1. An analysis of the RTS,S malaria vaccine in Africa shows it decreased toddler deaths by 13 percent. PATH’s John Bawa speaks with Science about these remarkable results.
    Published: October 2023
  2. From health data exchanges to a telemedicine task force, PATH’s Varun Kaul and co-author Anirban Sarma break down eight approaches that the G20 could take to strengthen digital health across its member states.
    Published: October 2023
  3. The novel meningococcal conjugate vaccine, Men5CV, developed by the Serum Institute of India and PATH, is expected to be more affordable and accessible to meningitis belt countries.
    Published: October 2023
  4. The Africa Centres for Disease Control and Prevention, the Clinton Health Access Initiative, and PATH examined the current and planned vaccine manufacturing capacity in Africa.
    Published: October 2023

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

971 Item s
971 Item s
    Date
    From
    To
  1. PATH, as a major sub-partner on the consortium led by FHI360, launches the STRengthening Infectious disease DEtection Systems (STRIDES) Activity: a new Activity funded by USAID to combat epidemics, pandemics, and novel infectious disease threats.
    Published: November 2024
    Press Release
  2. Published: October 2024
    Announcement
  3. The trial aimed to determine how well a new, injectable, non-replicating rotavirus vaccine candidate works, compared to a licensed oral rotavirus vaccine in preventing infant diarrhea.
    Published: October 2024
    Announcement
  4. Published: October 2024
    Announcement
  5. Published: October 2024
    Press Release